EUVIMEDEUVIMED entdecken
Kommentar

Novel Approach to Evaluate the Role of Selexipag in Pulmonary Arterial Hypertension

John Granton, Gerry Coghlan

JAMA Network Open · 2024

DOI: 10.1001/jamanetworkopen.2024.34644 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA Network Open, 2024. Verfasst von John Granton und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respirology, Faculty of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Acetamides, Pyrazines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetamidesPyrazinesHumansPulmonary Arterial HypertensionMaleFemaleMiddle AgedHypertension, PulmonaryAdultAntihypertensive AgentsAged

Substanzen

selexipagAcetamidesPyrazinesAntihypertensive Agents

Autor:innen und Institutionen

  • Division of Respirology, Faculty of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Cardiology, Royal Free London NHS Foundation Trust, London, United Kingdom.

Zitieren

APA

Granton, J., & Coghlan, G. (2024). Novel Approach to Evaluate the Role of Selexipag in Pulmonary Arterial Hypertension. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.34644

Vancouver

Granton J, Coghlan G. Novel Approach to Evaluate the Role of Selexipag in Pulmonary Arterial Hypertension. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.34644

BibTeX
@article{Granton2024,
  author = {Granton, John and Coghlan, Gerry},
  title = {Novel Approach to Evaluate the Role of Selexipag in Pulmonary Arterial Hypertension},
  journal = {JAMA Network Open},
  year = {2024},
  doi = {10.1001/jamanetworkopen.2024.34644}
}
Kostenlos starten →